| Literature DB >> 36204396 |
Indarto Dono1,2,3, Dwipajati Dwipajati2,4, Paramasari Dirgahayu2,5, Yohanes Cakrapradipta Wibowo3, Yoga Mulia Pratama3,6.
Abstract
Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health issue. Diet and physical exercise are modifiable factors that influence the glycaemic status of patients with T2DM. We aimed to investigate the acute effects of breakfast fruits meal sequence and postprandial exercise on the blood glucose level and dipeptidyl peptidase 4 (DPP4) activity among type 2 diabetes mellitus patients.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36204396 PMCID: PMC9532157 DOI: 10.1155/2022/4875993
Source DB: PubMed Journal: J Obes ISSN: 2090-0708
Basic characteristics of research participants from four different groups.
| Characteristics | FL ( | FF ( | FL + PE ( | FF + PE ( |
|
|---|---|---|---|---|---|
| Age (years) | 53.50 ± 7.28 | 55.88 ± 4.19 | 54.11 ± 6.07 | 55.56 ± 3.54 | ns |
|
| |||||
| Duration of type 2 diabetes mellitus (years) | 4.65 ± 3.48 | 7.31 ± 3.43 | 3.39 ± 3.71 | 5.56 ± 3.60 | ns |
|
| |||||
|
| |||||
| Male | 1 (10.00%) | 1 (12.50%) | 1 (11.11%) | 1 (11.11%) | ns |
| Female | 9 (90.00%) | 7 (87.50%) | 8 (88.89%) | 8 (88.89%) | |
|
| |||||
|
| 153.13 ± 7.21 | 152.14 ± 5.17 | 149.83 ± 3.86 | 155.32 ± 8.49 | ns |
| 2 h PPG (mg/dL) | 316.90 ± 154.60 | 316.50 ± 125.05 | 307.33 ± 150.46 | 267.67 ± 87.89 | ns |
2 h PPG, 2 h postprandial glucose. Parts of this table are in accordance with and with permission from our previous studies [17, 18]. statistical differences were performed by one-way anova. The Kruskall–Wallis test was used to determine the statistical significances, statistics were conducted by using Fischer exact test.
Figure 1Nutritional intakes on pre-treatment and day 1 and day 7 of a 7-day course of treatment were as follows: (a) energy, (b) carbohydrates, (c) dietary fibre, (d) protein (gr), and (e) lipids (gr). Generally, no significant differences were found in macronutrients consumption on days 1 and 7 except protein consumption on day 1. ns = non-significant, p < 0.05.
Figure 2(a) Fasting blood glucose (FBG) level on day 1 and day 7 of a 7-day course of treatment; (b) one-hour postprandial glucose (1 h PPG) level on day 1 and day 7 of a 7-day course of treatment; (c) fasting DPP4 activity; and (d) 1 h DPP4 activity on day 1 and day 7. ns = non-significant, p < 0.05.
The mean changes of each treatment after a 7-day course of treatment.
| FL | FF | FL + PE | FF + PE |
| |
|---|---|---|---|---|---|
| FBG | −51.80 ± 70.23 | 9.00 ± 37.86 | −36.78 ± 42.42 | −24.78 ± 47.09 | a, d |
| 1 h PPG | −33.20 ± 90.86 | −22.38 ± 68.43 | −50.89 ± 57.46 | −6.33 ± 51.04 | ns |
| Fasting DPP4 activity | −36.63 ± 94.27 | −29.85 ± 80.29 | −75.08 ± 41.75 | −7.17 ± 73.01 |
|
| 1 h DPP4 actvity | 24.80 ± 93.28 | −5.98 ± 74.01 | −68.26 ± 42.11 | −32.05 ± 36.32 |
|
significant difference between FL and FF. significant difference between FL and FL + PE. significant difference between FL and FF + PE. significant difference between FF and FL + PE. significant difference between FF and FF + PE. significant difference between FL + PE and FF + PE. ns = non-significant.